These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1794 related articles for article (PubMed ID: 11704865)

  • 1. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.
    Parada Y; Banerji L; Glassford J; Lea NC; Collado M; Rivas C; Lewis JL; Gordon MY; Thomas NS; Lam EW
    J Biol Chem; 2001 Jun; 276(26):23572-80. PubMed ID: 11323429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1).
    Donjerković D; Mueller CM; Scott DW
    Eur J Immunol; 2000 Apr; 30(4):1154-61. PubMed ID: 10760805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1).
    Turturro F; Frist AY; Arnold MD; Seth P; Pulford K
    Oncogene; 2001 Jul; 20(33):4466-75. PubMed ID: 11494142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels.
    Chandramohan V; Jeay S; Pianetti S; Sonenshein GE
    J Immunol; 2004 May; 172(9):5522-7. PubMed ID: 15100294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of p27Kip1 arrests neuroblastoma cell growth.
    Matsuo T; Seth P; Thiele CJ
    Med Pediatr Oncol; 2001 Jan; 36(1):97-9. PubMed ID: 11464914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
    Ezhevsky SA; Toyoshima H; Hunter T; Scott DW
    Mol Biol Cell; 1996 Apr; 7(4):553-64. PubMed ID: 8730099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
    Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
    J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
    Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
    J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.
    Alexander K; Hinds PW
    Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
    Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
    J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.
    Brennan P; Babbage JW; Burgering BM; Groner B; Reif K; Cantrell DA
    Immunity; 1997 Nov; 7(5):679-89. PubMed ID: 9390691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin is a potent survival factor in mesangial cells: role of the PI3-kinase/Akt pathway.
    Hiromura K; Monkawa T; Petermann AT; Durvasula RV; Shankland SJ
    Kidney Int; 2002 Apr; 61(4):1312-21. PubMed ID: 11918738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.